The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic-Therapeutic Implications.
BRAF mutation
CFC
Cardiofaciocutaneous syndrome
KRAS mutation
MEK1 mutation
MEK2 mutation
RASopathies
hypertrophic cardiomyopathy
neurodevelopment
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
09
10
2023
revised:
16
11
2023
accepted:
21
11
2023
medline:
23
12
2023
pubmed:
23
12
2023
entrez:
23
12
2023
Statut:
epublish
Résumé
Cardiofaciocutaneous (CFC) syndrome is one of the rarest RASopathies characterized by multiple congenital ectodermal, cardiac and craniofacial abnormalities with a mild to severe ocular, gastrointestinal and neurological involvement. It is an autosomal dominant syndrome, with complete penetrance, caused by heterozygous pathogenic variants in the genes
Identifiants
pubmed: 38136934
pii: genes14122111
doi: 10.3390/genes14122111
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM